Oral vinorelbine versus intravenous vinorelbine, in combination with epirubicin as first-line chemotherapy in Chinese patients with metastatic breast cancer

Oral VRL offers easier administration, better quality of life, and cost saving. This study aimed to evaluate the treatment efficacy in terms of tumor response of the two formulations of vinorelbine (VRL, oral and IV) in combination with epirubicin (EPI); and the effect of EPI co-administration on VR...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Liang, Wang, Xiaojia, Zhou, Liheng, Di, Lijun, Zheng, Hongyu, Jiang, Zefei, Wang, Yongsheng, Song, Xiangqun, Feng, Jifeng, Yu, Shiying, Liu, Yunpeng, Zheng, Hong, Shen, Kunwei, Tong, Zhongsheng, Shao, Zhimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994442/
https://www.ncbi.nlm.nih.gov/pubmed/31838561
http://dx.doi.org/10.1007/s00280-019-04000-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994442/
https://www.ncbi.nlm.nih.gov/pubmed/31838561
http://dx.doi.org/10.1007/s00280-019-04000-3

Ejemplares similares